Central Compartment Neck Dissection in Laryngeal and Hypopharyngeal Squamous Cell Carcinoma : Clinical Considerations

Metastatic lymph node involvement represents the most relevant prognostic factor in head and neck squamous cell carcinomas (HNSCCs), invariably affecting overall survival, disease-specific survival, and relapse-free survival. Among HNSCCs, laryngeal and hypopharyngeal cancers are known to be at highest risk to metastasize to the central neck compartment (CNC). However, prevalence and prognostic implications related to the CNC involvement are not well defined yet, and controversies still exist regarding the occult metastasis rate. Guidelines for the management of CNC in laryngeal and hypopharyngeal cancers are vague, resulting in highly variable selection criteria for the central neck dissection among different surgeons and institutions. With this review, the authors intend to reappraise the existing data related to the involvement of CNC in laryngeal and hypopharyngeal malignancies, in the attempt to define the principles of management while highlighting the debated aspects that are lacking in evidence and consensus. Furthermore, as definition and boundaries of the CNC have changed over the years, an up-to-date anatomical-surgical description of the CNC is provided.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Cancers - 15(2023), 3 vom: 28. Jan.

Sprache:

Englisch

Beteiligte Personen:

Deganello, Alberto [VerfasserIn]
Ruaro, Alessandra [VerfasserIn]
Gualtieri, Tommaso [VerfasserIn]
Berretti, Giulia [VerfasserIn]
Rampinelli, Vittorio [VerfasserIn]
Borsetto, Daniele [VerfasserIn]
Russo, Sabino [VerfasserIn]
Boscolo-Rizzo, Paolo [VerfasserIn]
Ferrari, Marco [VerfasserIn]
Bussu, Francesco [VerfasserIn]

Links:

Volltext

Themen:

Central neck dissection
Elective neck dissection
Hypopharyngeal cancer
Journal Article
Laryngeal cancer
Level VI
Management
Paratracheal lymph nodes dissection
Prognosis
Review
Squamous cell carcinoma

Anmerkungen:

Date Revised 13.02.2023

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/cancers15030804

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM352754818